{"id":"gsk1325756","safety":{"commonSideEffects":[{"effect":"Nasopharyngitis","drugRate":"11.7%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":111,"totalAffected":13,"trialsReporting":2},{"effect":"Upper respiratory tract infection","drugRate":"4.9%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":102,"totalAffected":5,"trialsReporting":1},{"effect":"Back pain","drugRate":"3.6%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":111,"totalAffected":4,"trialsReporting":2},{"effect":"Headache","drugRate":"2.5%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":119,"totalAffected":3,"trialsReporting":3},{"effect":"Nausea","drugRate":"5.9%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":17,"totalAffected":1,"trialsReporting":2},{"effect":"Fatigue","drugRate":"11.1%","organSystem":"General disorders","placeboRate":"","totalAtRisk":9,"totalAffected":1,"trialsReporting":1},{"effect":"Malaise","drugRate":"11.1%","organSystem":"General disorders","placeboRate":"","totalAtRisk":9,"totalAffected":1,"trialsReporting":1},{"effect":"Cough","drugRate":"11.1%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":9,"totalAffected":1,"trialsReporting":1},{"effect":"Dyspnoea","drugRate":"11.1%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":9,"totalAffected":1,"trialsReporting":1},{"effect":"Hyperhidrosis","drugRate":"11.1%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":9,"totalAffected":1,"trialsReporting":1},{"effect":"Diarrhoea","drugRate":"3.1%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":32,"totalAffected":1,"trialsReporting":3},{"effect":"Vessel puncture site haematoma","drugRate":"12.5%","organSystem":"General disorders","placeboRate":"","totalAtRisk":8,"totalAffected":1,"trialsReporting":1},{"effect":"Abdominal pain upper","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":9,"totalAffected":0,"trialsReporting":1},{"effect":"Cystitis","drugRate":"0.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":9,"totalAffected":0,"trialsReporting":1},{"effect":"Epistaxis","drugRate":"0.0%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":15,"totalAffected":0,"trialsReporting":1},{"effect":"Vomiting","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":23,"totalAffected":0,"trialsReporting":2},{"effect":"Abnormal faeces","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":8,"totalAffected":0,"trialsReporting":1},{"effect":"Bursitis","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":8,"totalAffected":0,"trialsReporting":1},{"effect":"Musculoskeletal chest pain","drugRate":"0.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":8,"totalAffected":0,"trialsReporting":1},{"effect":"Somnolence","drugRate":"0.0%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":8,"totalAffected":0,"trialsReporting":1},{"effect":"Dyspepsia","drugRate":"0.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":8,"totalAffected":0,"trialsReporting":1},{"effect":"Dermatitis contact","drugRate":"0.0%","organSystem":"Skin and subcutaneous tissue disorders","placeboRate":"","totalAtRisk":8,"totalAffected":0,"trialsReporting":1}],"seriousAdverseEvents":[{"event":"Electrocardiogram T wave abnormal","detail":"Investigations. 1 trial(s).","severity":"serious","incidence":"6.7%"},{"event":"Osteoarthritis","detail":"Musculoskeletal and connective tissue disorders. 2 trial(s).","severity":"serious","incidence":"1.8%"},{"event":"Chronic gastritis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Large intestine polyp","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Angina pectoris","detail":"Cardiac disorders. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Cardiac neoplasm unspecified","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Oesophageal adenocarcinoma","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Prostate cancer","detail":"Neoplasms benign, malignant and unspecified (incl cysts and polyps). 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Decreased appetite","detail":"Metabolism and nutrition disorders. 1 trial(s).","severity":"serious","incidence":"1.0%"},{"event":"Chronic obstructive pulmonary disease","detail":"Respiratory, thoracic and mediastinal disorders. 2 trial(s).","severity":"serious","incidence":"0.9%"},{"event":"Pneumonia","detail":"Infections and infestations. 2 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Arthritis bacterial","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Metapneumovirus infection","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Perichondritis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pilonidal cyst","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Psoas abscess","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pyelonephritis acute","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Septic shock","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Anal prolapse","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Faecaloma","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Gastrointestinal perforation","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Gastrooesophageal reflux disease","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Haemorrhoids","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Large intestine perforation","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Lower gastrointestinal haemorrhage","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pancreatitis","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pancreatitis chronic","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Small intestinal obstruction","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Epistaxis","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Haemoptysis","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"}]},"_chembl":{"chemblId":"CHEMBL3039531","moleculeType":"Small molecule","molecularWeight":"441.91"},"_sources":{"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (4 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T09:38:58.591244+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T06:09:52.229Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":3,"lastValidatedAt":"2026-04-20T09:39:05.826415+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT03457727","phase":"PHASE1","title":"GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-03-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":40},{"nctId":"NCT03250689","phase":"PHASE2","title":"Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-11-15","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":19},{"nctId":"NCT02927431","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-01-19","conditions":"Virus Diseases","enrollment":10},{"nctId":"NCT03034967","phase":"PHASE2","title":"Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-04-25","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":614},{"nctId":"NCT03170232","phase":"PHASE2","title":"A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-10-16","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":54},{"nctId":"NCT02469298","phase":"PHASE2","title":"Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-06-01","conditions":"Virus Diseases","enrollment":45},{"nctId":"NCT02453022","phase":"PHASE1","title":"A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-05-18","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":18},{"nctId":"NCT01267006","phase":"PHASE1","title":"Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11-05","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":40},{"nctId":"NCT02130193","phase":"PHASE2","title":"Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-13","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":102},{"nctId":"NCT01209104","phase":"PHASE1","title":"Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-04-14","conditions":"Nutritional Status","enrollment":32},{"nctId":"NCT01209052","phase":"PHASE1","title":"First Time in Human Study With GSK1325756","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-10-15","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":58},{"nctId":"NCT01453478","phase":"PHASE1","title":"A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-10-12","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":20},{"nctId":"NCT02169583","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-06-12","conditions":"Infections, Respiratory Tract","enrollment":24},{"nctId":"NCT02201303","phase":"PHASE1","title":"Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-01-13","conditions":"Infections, Respiratory Syncytial Virus","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"structuredTrialResults":[{"hr":"0.08","nctId":"NCT03034967","phase":"PHASE2","pValue":"","ciLower":"0.00","ciUpper":"0.66","endpoint":"Change From Baseline in Respiratory Symptoms Measured by Evaluating Respiratory Symptoms (E-RS) in COPD. E-RS: COPD Total Score","enrollment":614},{"hr":"0.06","nctId":"NCT02130193","phase":"PHASE2","pValue":"0.87","ciLower":"-0.05","ciUpper":"0.18","endpoint":"Change From Baseline in FEV1 and FVC at the Indicated Time Points in Part B","enrollment":102}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"GSK1325756","genericName":"GSK1325756","companyName":"GlaxoSmithKline","companyId":"glaxosmithkline","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":11,"withResults":4},"validation":{"fieldsValidated":3,"lastValidatedAt":"2026-04-20T09:39:05.826415+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}